Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the FDA ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

The US Food and Drug Administration has approved a generic once ... type 2 diabetes (T2D), as an adjunct to diet and exercise. The move follows the FDA’s approval last month of a generic version ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound ... The drug is designed to be used alongside a reduced-calorie diet and increased physical activity, offering ...

The the US Food and Drug Administration (FDA) has approved the first medication to ... The agency said that along with the drug, a reduced-calorie diet and increased physical activity should ...

The Food and Drug Administration on Friday approved ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...

23, 2024 -- The FDA has approved the first prescription drug, Zepbound ... Studies have shown that when combined with a low-calorie diet and increased exercise, Zepbound improves OSA symptoms ...

It should be used with a reduced-calorie diet and ... the new FDA green light doesn't expand the number of people who may be eligible for the drug, since the sleep apnea approval is specifically ...